Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Cognitive dysfunction in individuals with cocaine use disorder: Potential moderating factors and pharmacological treatments.

Mahoney JJ.

Exp Clin Psychopharmacol. 2019 Jun;27(3):203-214. doi: 10.1037/pha0000245. Epub 2018 Dec 17.

PMID:
30556731
2.

Postnatal exposure to household disinfectants, infant gut microbiota and subsequent risk of overweight in children.

Tun MH, Tun HM, Mahoney JJ, Konya TB, Guttman DS, Becker AB, Mandhane PJ, Turvey SE, Subbarao P, Sears MR, Brook JR, Lou W, Takaro TK, Scott JA, Kozyrskyj AL; CHILD Study Investigators.

CMAJ. 2018 Sep 17;190(37):E1097-E1107. doi: 10.1503/cmaj.170809. Erratum in: CMAJ. 2018 Nov 12;190(45):E1341.

3.

The limited impact that cocaine use patterns have on neurocognitive functioning in individuals with cocaine use disorder.

Mahoney JJ 3rd, Kalechstein AD, Newton TF, De La Garza R 2nd.

J Psychopharmacol. 2017 Aug;31(8):989-995. doi: 10.1177/0269881117715606. Epub 2017 Jul 11.

PMID:
28695777
4.

The relationship between the Neuro-Quality of Life Depression and Anxiety Measures and the Personality Assessment Inventory in persons with epilepsy.

De Marco AP, Mahoney JJ 3rd, Aduen PA, Langer J, Bajo SD, Broshek DK.

Epilepsy Behav. 2017 May;70(Pt A):145-149. doi: 10.1016/j.yebeh.2017.02.008. Epub 2017 Apr 17.

PMID:
28427023
5.

Electrocardiographic characteristics in individuals with cocaine use disorder.

Mahoney JJ 3rd, Haile CN, De La Garza R 2nd, Thakkar H, Newton TF.

Am J Addict. 2017 Apr;26(3):221-227. doi: 10.1111/ajad.12524. Epub 2017 Mar 1.

PMID:
28248441
6.

Referring Providers' Preferences and Satisfaction with Neuropsychological Services.

Mahoney JJ 3rd, Bajo SD, De Marco AP, Arredondo BC, Hilsabeck RC, Broshek DK.

Arch Clin Neuropsychol. 2017 Jun 1;32(4):427-436. doi: 10.1093/arclin/acx007.

PMID:
28164213
7.

The relationship between premorbid IQ and neurocognitive functioning in individuals with cocaine use disorders.

Mahoney JJ, Kalechstein AD, De Marco AP, Newton TF, De La Garza R.

Neuropsychology. 2017 Mar;31(3):311-318. doi: 10.1037/neu0000344. Epub 2017 Jan 5.

PMID:
28054825
8.

Treadmill exercise improves fitness and reduces craving and use of cocaine in individuals with concurrent cocaine and tobacco-use disorder.

De La Garza R 2nd, Yoon JH, Thompson-Lake DG, Haile CN, Eisenhofer JD, Newton TF, Mahoney JJ 3rd.

Psychiatry Res. 2016 Nov 30;245:133-140. doi: 10.1016/j.psychres.2016.08.003. Epub 2016 Aug 9.

9.

Relative Utility of Performance and Symptom Validity Tests.

Copeland CT, Mahoney JJ, Block CK, Linck JF, Pastorek NJ, Miller BI, Romesser JM, Sim AH.

Arch Clin Neuropsychol. 2016 Feb;31(1):18-22. doi: 10.1093/arclin/acv065. Epub 2015 Nov 3.

PMID:
26537776
10.

Criterion Validity of the WAIS-IV Cognitive Proficiency Index (CPI).

Logue E, Scarisbrick DM, Thaler NS, Mahoney JJ 3rd, Block CK, Adams R, Scott J.

Clin Neuropsychol. 2015;29(6):777-87. doi: 10.1080/13854046.2015.1101490. Epub 2015 Oct 23.

PMID:
26494204
11.

Safety and Preliminary Efficacy of the Acetylcholinesterase Inhibitor Huperzine A as a Treatment for Cocaine Use Disorder.

De La Garza R 2nd, Verrico CD, Newton TF, Mahoney JJ 3rd, Thompson-Lake DG.

Int J Neuropsychopharmacol. 2015 Sep 12;19(3):pyv098. doi: 10.1093/ijnp/pyv098.

12.

Dopamine D3 receptor-preferring agonist enhances the subjective effects of cocaine in humans.

Newton TF, Haile CN, Mahoney JJ 3rd, Shah R, Verrico CD, De La Garza R 2nd, Kosten TR.

Psychiatry Res. 2015 Nov 30;230(1):44-9. doi: 10.1016/j.psychres.2015.07.073. Epub 2015 Jul 29.

13.

Application of programmable bio-nano-chip system for the quantitative detection of drugs of abuse in oral fluids.

Christodoulides N, De La Garza R 2nd, Simmons GW, McRae MP, Wong J, Newton TF, Smith R, Mahoney JJ III, Hohenstein J, Gomez S, Floriano PN, Talavera H, Sloan DJ, Moody DE, Andrenyak DM, Kosten TR, Haque A, McDevitt JT.

Drug Alcohol Depend. 2015 Aug 1;153:306-13. doi: 10.1016/j.drugalcdep.2015.04.026. Epub 2015 May 22.

14.

Genetic variation of the dopamine transporter (DAT1) influences the acute subjective responses to cocaine in volunteers with cocaine use disorders.

Brewer AJ 3rd, Nielsen DA, Spellicy CJ, Hamon SC, Gingrich J, Thompson-Lake DG, Nielsen EM, Mahoney JJ 3rd, Kosten TR, Newton TF, De La Garza R 2nd.

Pharmacogenet Genomics. 2015 Jun;25(6):296-304. doi: 10.1097/FPC.0000000000000137.

15.

The interaction between medical burden and anticholinergic cognitive burden on neuropsychological function in a geriatric primary care sample.

Block CK, Logue E, Thaler NS, Scarisbrick DM, Mahoney JJ 3rd, Scott J, Duff K.

Arch Clin Neuropsychol. 2015 Mar;30(2):105-13. doi: 10.1093/arclin/acu073. Epub 2014 Dec 30.

PMID:
25549761
16.

Withdrawal Symptoms and Nicotine Dependence Severity Predict Virtual Reality Craving in Cigarette-Deprived Smokers.

Thompson-Lake DG, Cooper KN, Mahoney JJ 3rd, Bordnick PS, Salas R, Kosten TR, Dani JA, De La Garza R 2nd.

Nicotine Tob Res. 2015 Jul;17(7):796-802. doi: 10.1093/ntr/ntu245. Epub 2014 Dec 4.

17.

A comparison of impulsivity, depressive symptoms, lifetime stress and sensation seeking in healthy controls versus participants with cocaine or methamphetamine use disorders.

Mahoney JJ 3rd, Thompson-Lake DG, Cooper K, Verrico CD, Newton TF, De La Garza R 2nd.

J Psychopharmacol. 2015 Jan;29(1):50-6. doi: 10.1177/0269881114560182. Epub 2014 Nov 25.

PMID:
25424624
18.

Sapropterin Dihydrochloride Mixed With Common Foods and Beverages.

Jurecki ER, Cunningham A, Mahoney JJ, Tingley D, Chung S, James N, Cohen-Pfeffer JL.

Top Clin Nutr. 2014 Oct;29(4):325-331.

19.

Diabetes wellness care: a successful employer-endorsed program for employees.

Bevis CC, Nogle JM, Forges B, Chen PC, Sievers D, Lucas KR, Mahoney JJ, Crawford JM.

J Occup Environ Med. 2014 Oct;56(10):1052-61. doi: 10.1097/JOM.0000000000000231.

PMID:
25285827
20.

The relationship between sleep and drug use characteristics in participants with cocaine or methamphetamine use disorders.

Mahoney JJ 3rd, De La Garza R 2nd, Jackson BJ, Verrico CD, Ho A, Iqbal T, Newton TF.

Psychiatry Res. 2014 Oct 30;219(2):367-71. doi: 10.1016/j.psychres.2014.05.026. Epub 2014 May 27.

21.

Short-term, low-dose varenicline administration enhances information processing speed in methamphetamine-dependent users.

Kalechstein AD, Mahoney JJ 3rd, Verrico CD, De La Garza R 2nd.

Neuropharmacology. 2014 Oct;85:493-8. doi: 10.1016/j.neuropharm.2014.05.045. Epub 2014 Jun 12.

PMID:
24930359
22.

Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: a randomized, double blind, placebo-controlled human laboratory study.

Verrico CD, Haile CN, Mahoney JJ 3rd, Thompson-Lake DG, Newton TF, De La Garza R 2nd.

Drug Alcohol Depend. 2014 Aug 1;141:72-8. doi: 10.1016/j.drugalcdep.2014.05.008. Epub 2014 May 28.

23.

Prevalence of medication management by community pharmacists in patients of a Newfoundland family medicine clinic.

Dillon CM, Mahoney JJ, Genge TL, Conway AE, Stringer KC.

Can Pharm J (Ott). 2014 May;147(3):154-8. doi: 10.1177/1715163514528869. No abstract available.

24.

Sapropterin dihydrochloride use in pregnant women with phenylketonuria: an interim report of the PKU MOMS sub-registry.

Grange DK, Hillman RE, Burton BK, Yano S, Vockley J, Fong CT, Hunt J, Mahoney JJ, Cohen-Pfeffer JL; Phenylketonuria Demographics Outcomes and Safety (PKUDOS) registry; Maternal Phenylketonuria Observational Program (PKU MOMS) sub-registry.

Mol Genet Metab. 2014 May;112(1):9-16. doi: 10.1016/j.ymgme.2014.02.016. Epub 2014 Mar 12.

25.

A variant in ANKK1 modulates acute subjective effects of cocaine: a preliminary study.

Spellicy CJ, Harding MJ, Hamon SC, Mahoney JJ 3rd, Reyes JA, Kosten TR, Newton TF, De La Garza R 2nd, Nielsen DA.

Genes Brain Behav. 2014 Jul;13(6):559-64. doi: 10.1111/gbb.12121. Epub 2014 Mar 17.

26.

Safety and efficacy of varenicline to reduce positive subjective effects produced by methamphetamine in methamphetamine-dependent volunteers.

Verrico CD, Mahoney JJ 3rd, Thompson-Lake DG, Bennett RS, Newton TF, De La Garza R 2nd.

Int J Neuropsychopharmacol. 2014 Feb;17(2):223-33. doi: 10.1017/S146114571300134X.

27.

Assessment of safety, cardiovascular and subjective effects after intravenous cocaine and lofexidine.

De La Garza R 2nd, Galloway GP, Newton TF, Mendelson J, Haile CN, Dib E, Hawkins RY, Chen CY, Mahoney JJ 3rd, Mojsiak J, Lao G, Anderson A, Kahn R.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Apr 3;50:44-52. doi: 10.1016/j.pnpbp.2013.11.013. Epub 2013 Dec 4.

28.

Preliminary findings of the effects of rivastigmine, an acetylcholinesterase inhibitor, on working memory in cocaine-dependent volunteers.

Mahoney JJ 3rd, Kalechstein AD, Verrico CD, Arnoudse NM, Shapiro BA, De La Garza R 2nd.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Apr 3;50:137-42. doi: 10.1016/j.pnpbp.2013.11.001. Epub 2013 Nov 12.

29.

Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression.

Haile CN, Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Foulkes A, Iqbal S, Mahoney JJ 3rd, De La Garza R 2nd, Charney DS, Newton TF, Mathew SJ.

Int J Neuropsychopharmacol. 2014 Feb;17(2):331-6. doi: 10.1017/S1461145713001119. Epub 2013 Oct 8.

30.

Effects of methamphetamine on the noradrenergic activity biomarker salivary alpha-amylase.

Haile CN, De La Garza R 2nd, Mahoney JJ 3rd, Newton TF.

Drug Alcohol Depend. 2013 Dec 1;133(2):759-62. doi: 10.1016/j.drugalcdep.2013.07.029. Epub 2013 Aug 8.

31.

The impact of self-reported life stress on current impulsivity in cocaine dependent adults.

Ross EL, Yoon JH, Mahoney JJ 3rd, Omar Y, Newton TF, De La Garza R 2nd.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Oct 1;46:113-9. doi: 10.1016/j.pnpbp.2013.06.002. Epub 2013 Jun 21.

32.

Roundtable--the changing oncology landscape: evolution or revolution?

Beveridge R, Fox J, Higgins SA, Kohn M, Mahoney JJ, Newcomer LN, von Eschenbach A, Goodman C.

J Natl Compr Canc Netw. 2013 May;11(5 Suppl):636-8.

PMID:
23704232
33.

Neurocognitive effects following an overnight call shift on faculty anesthesiologists.

Chang LC, Mahoney JJ 3rd, Raty SR, Ortiz J, Apodaca S, De La Garza R 2nd.

Acta Anaesthesiol Scand. 2013 Sep;57(8):1051-7. doi: 10.1111/aas.12120. Epub 2013 Apr 17.

PMID:
23593975
34.

Performance of a new meter designed for assisted monitoring of blood glucose and point-of-care testing.

Macrury S, Srinivasan A, Mahoney JJ.

J Diabetes Sci Technol. 2013 Mar 1;7(2):389-98.

35.

The influence of smoking cigarettes on the high and desire for cocaine among active cocaine users.

Brewer AJ 3rd, Mahoney JJ 3rd, Nerumalla CS, Newton TF, De La Garza R 2nd.

Pharmacol Biochem Behav. 2013 May;106:132-6. doi: 10.1016/j.pbb.2013.03.008. Epub 2013 Mar 27.

36.

Automated glycemic pattern analysis can improve health care professional efficiency and accuracy.

Katz LB, Dirani RG, Li G, Randoll RA, Mahoney JJ.

J Diabetes Sci Technol. 2013 Jan 1;7(1):163-6.

37.

The impact of disulfiram treatment on the reinforcing effects of cocaine: a randomized clinical trial.

Haile CN, De La Garza R 2nd, Mahoney JJ 3rd, Nielsen DA, Kosten TR, Newton TF.

PLoS One. 2012;7(11):e47702. doi: 10.1371/journal.pone.0047702. Epub 2012 Nov 8.

38.

The impact of reducing cardiovascular medication copayments on health spending and resource utilization.

Choudhry NK, Fischer MA, Avorn JL, Lee JL, Schneeweiss S, Solomon DH, Berman C, Jan S, Lii J, Mahoney JJ, Shrank WH.

J Am Coll Cardiol. 2012 Oct 30;60(18):1817-24. doi: 10.1016/j.jacc.2012.06.050. Epub 2012 Oct 3.

39.

d-Cycloserine administration does not affect neurocognition in concurrent cocaine- and nicotine-dependent volunteers.

Kalechstein AD, Yoon JH, Mahoney JJ 3rd, Newton TF, Chang L, De La Garza R 2nd.

Pharmacol Biochem Behav. 2012 Dec;103(2):403-7. doi: 10.1016/j.pbb.2012.08.011. Epub 2012 Aug 31.

PMID:
22960612
40.

Importance of blood glucose meter and carbohydrate estimation accuracy.

Virdi NS, Mahoney JJ.

J Diabetes Sci Technol. 2012 Jul 1;6(4):921-6.

41.

Modafinil, but not escitalopram, improves working memory and sustained attention in long-term, high-dose cocaine users.

Kalechstein AD, Mahoney JJ 3rd, Yoon JH, Bennett R, De la Garza R 2nd.

Neuropharmacology. 2013 Jan;64:472-8. doi: 10.1016/j.neuropharm.2012.06.064. Epub 2012 Jul 13.

PMID:
22796108
42.

The relationship between lifetime stress and addiction severity in cocaine-dependent participants.

Mahoney JJ 3rd, Newton TF, Omar Y, Ross EL, De La Garza R 2nd.

Eur Neuropsychopharmacol. 2013 May;23(5):351-7. doi: 10.1016/j.euroneuro.2012.05.016. Epub 2012 Jun 28.

PMID:
22748418
43.

Effects of D-cycloserine on cue-induced craving and cigarette smoking among concurrent cocaine- and nicotine-dependent volunteers.

Yoon JH, Newton TF, Haile CN, Bordnick PS, Fintzy RE, Culbertson C, Mahoney JJ 3rd, Hawkins RY, Labounty KR, Ross EL, Aziziyeh AI, De La Garza R 2nd.

Addict Behav. 2013 Feb;38(2):1518-26. doi: 10.1016/j.addbeh.2012.03.022. Epub 2012 Mar 26.

44.

Effect of disinfectants on glucose monitors.

Mahoney JJ, Lim CG.

J Diabetes Sci Technol. 2012 Jan 1;6(1):81-5.

45.

Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Haile CN, Mahoney JJ 3rd, Newton TF, De La Garza R 2nd.

Pharmacol Ther. 2012 May;134(2):260-77. doi: 10.1016/j.pharmthera.2012.01.010. Epub 2012 Jan 31. Review.

46.

Noradrenergic α₁ receptor antagonist treatment attenuates positive subjective effects of cocaine in humans: a randomized trial.

Newton TF, De La Garza R 2nd, Brown G, Kosten TR, Mahoney JJ 3rd, Haile CN.

PLoS One. 2012;7(2):e30854. doi: 10.1371/journal.pone.0030854. Epub 2012 Feb 3.

47.

Rivastigmine reduces "Likely to use methamphetamine" in methamphetamine-dependent volunteers.

De La Garza R 2nd, Newton TF, Haile CN, Yoon JH, Nerumalla CS, Mahoney JJ 3rd, Aziziyeh A.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Apr 27;37(1):141-6. doi: 10.1016/j.pnpbp.2011.12.014. Epub 2011 Dec 30.

48.

The effect of an instant hand sanitizer on blood glucose monitoring results.

Mahoney JJ, Ellison JM, Glaeser D, Price D.

J Diabetes Sci Technol. 2011 Nov 1;5(6):1444-8.

49.

Acute modafinil exposure reduces daytime sleepiness in abstinent methamphetamine-dependent volunteers.

Mahoney JJ, Jackson BJ, Kalechstein AD, De La Garza R 2nd, Chang LC, Newton TF.

Int J Neuropsychopharmacol. 2012 Oct;15(9):1241-9. doi: 10.1017/S1461145711001805. Epub 2012 Jan 4.

50.

Low dose, short-term rivastigmine administration does not affect neurocognition in methamphetamine dependent individuals.

Kalechstein AD, Yoon JH, Croft DE, Jaeggi S, Mahoney JJ 3rd, De La Garza R 2nd.

Pharmacol Biochem Behav. 2011 Sep;99(3):423-7. doi: 10.1016/j.pbb.2011.05.013. Epub 2011 May 23.

PMID:
21624391

Supplemental Content

Loading ...
Support Center